Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06991036 · ClinicalTrials.gov registry record · NA
Validation of Plant-Based Vegan Meal for Gastric Emptying Testing in 10 Healthy Subjects
A NA study of Gastroparesis and Gastric Emptying, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT06991036: Completed NA study of Gastroparesis and Gastric Emptying, sponsored by Mayo Clinic.
NCT06991036 is a NA study of Gastroparesis and Gastric Emptying that has completed, run by Mayo Clinic. The registered enrollment target is 10 participants, below the 302-participant average among 44 other Gastroparesis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06991036, a NA study of Gastroparesis and Gastric Emptying, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to compare the stomach emptying function using a current standard meal which includes eggs and our new vegan meal alternatives for patients who are not able to eat eggs.
Primary Outcome
Gastric emptying T half is measured using gastric emptying scintigraphy, which involves taking a meal with radioactive tracer and measuring the time it takes for 50% of the meal to leave the stomach. Results are reported in minutes.
Conditions Studied
Interventions
- OTHER Gastric emptying test
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-02-03 |
| Est. Completion | 2025-04-16 |
| Phase | NA |
What the finished NCT06991036 record still lists
NCT06991036 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 302-participant average among 44 other Gastroparesis trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Gastroparesis appearing as the primary indexed condition, and to 1 intervention - of which Gastric emptying test is the first listed.
NCT06991036 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT06991036 about?
NCT06991036 is a clinical study titled "Validation of Plant-Based Vegan Meal for Gastric Emptying Testing in 10 Healthy Subjects". The purpose of this research study is to compare the stomach emptying function using a current standard meal which includes eggs and our new vegan meal alternatives for patients who are not able to eat eggs.
What is the current status of trial NCT06991036?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2025-02-03. Estimated completion is 2025-04-16.
What conditions does trial NCT06991036 study?
This clinical trial studies the following conditions: Gastroparesis, Gastric Emptying.
What interventions are being tested in trial NCT06991036?
The interventions under investigation include: Gastric emptying test (OTHER).
Who is sponsoring clinical trial NCT06991036?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06991036 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastroparesis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06991036's enrollment target sits among peer trials
10 41st of 44 higher than 2 of 44 other Gastroparesis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gastroparesis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Use of Body Surface Gastric Mapping in Assessing the Clinical Success of G-POEM
RECRUITING · NA
-
Compassionate Use of Domperidone for Refractory Gastroparesis
RECRUITING · NA
-
Central and Peripheral Effects of Cognitive Behavioral Therapy on Brain-Gut Axis Signaling in Gastroparetic Patients
RECRUITING · NA
-
Transpyloric Stenting As a Predictor for G-POEM for Refractory Gastroparesis
RECRUITING · NA
-
Study of Enhanced Programming Stimulation with the Enterra® Therapy System
RECRUITING · NA
-
Study of Enterra Programming with Nocturnal Cycling in Gastroparetics
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI